Ischemická cévní mozková příhoda nebo tranzitorní ischemická ataka kardioembolické etiologie a jejich sekundární prevence
| Title in English | Ischemic stroke or transient ischemic attack of cardioembolic etiology and their secondary prevention |
|---|---|
| Authors | |
| Year of publication | 2020 |
| MU Faculty or unit | |
| Web | https://kdp.uzis.cz/index.php?pg=kdp&id=3 |
| Description | Ischemic strokes (iCMP) account for 88% of all strokes, in the Czech Republic the incidence of iCMP is currently 211 cases per 100 000 population per year and the prevalence is estimated at 240 000 cases. The most common type of ischemic stroke is cardioembolic stroke and its most common cause is non-valvular atrial fibrillation (AF) or atrial flutter. FS is the most common arrhythmia in the adult population. For primary and secondary prevention of iCMP in patients with FS, anticoagulant therapy with a vitamin K antagonist (warfarin) or direct oral anticoagulants (DOACs) factor Xa inhibitors (apixaban, edoxaban, rivaroxaban) and factor IIa inhibitor (dabigatran) is indicated. The main objective of this clinical guideline is to provide recommendations for the care of adult patients with iCMP and TIA based on the best available evidence. |